June 17, 2021 -- Vectron Biosolutions announced it recently raised $2.7 million and will buy a bacterial secretion platform from Utah-based T3S Technologies.
T3S's secretion platform is based on high-level expression followed by true secretion of proteins and will allow Vectron to boost its protein production offering, according to the company. Dynamk Capital, a growth equity and venture capital firm, led the financing round, Vectron said.